Zacks Investment Research
05 Nov 2026, 16:46 UTC · 1h ago
Can Higher Premiums Help Humana Beat Q3 Earnings Estimates?
Impact · against what's priced in
The article provides no catalyst for Humana as the projected Q3 losses and revenue growth are consistent with current market expectations. The prediction of an earnings beat is a common Zacks output and does not outweigh the priced-in consensus of significant year-over-year earnings contraction.
- HUM+0.00
Already priced in
- The price assumes
The 25% Medicare Advantage membership growth for 2026, which is reflected in the current revenue run rate.
The projected 23.9% year-over-year revenue growth for Q3 and 24.3% for the full year align with the membership growth and revenue run rate the market has already absorbed.
What HUM's price assumes · Sep 1
Top 2 movers · tap to explore
